Alihussein N. Dohadwalla
13Patents
5h-index
29Co-inventors
62Inventor score
Filing activity: Apr 26, 1977 → Jun 7, 1995
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4900727A | 4H-1-benzopyran-4-one compounds which have anti-inflamatory or immunodulating action | Chemistry; Metallurgy | 64 | Expired |
| US4578399A | Use of the diterpene derivative forskolin for immunostimulation | Human Necessities | 23 | Expired |
| US4118508A | Pharmacologically effective substance from plants belonging to the family of Labiatae | Chemistry; Metallurgy | 23 | Expired |
| US4482556A | Pyrimido (6,1-a)isoquinolin-4-one derivatives | Chemistry; Metallurgy | 11 | Expired |
| US4724238A | Method of treating inflammatory diseases with labdan derivatives | Human Necessities | 6 | Expired |
| US4603137A | Immunosuppressive chromone alkaloid | Human Necessities | 5 | Expired |
| US5141942A | Pharmaceutical compositions comprising labdane diterpenoid derivatives and pyrimido(6,1-a)isoquinolin-4-one derivatives and their use | Human Necessities | 3 | Expired |
| US4598148A | Pyrimido(6-1-a)isoquinolin-4-one derivatives | Chemistry; Metallurgy | 3 | Expired |
| US5821252A | Method of blocking nerve conduction by treatment with branched-chain esters of 2-4-(2-piperidine-ethoxy)-benzoyl!-benzoic acid and pharmaceutically acceptable salts thereof | Human Necessities | 1 | Expired |
| US5252598A | Labdane derivatives, a process for their preparation, and their use as medicaments | Chemistry; Metallurgy | 0 | Expired |
| US4590197A | 9,10-substituted 2-mesitylimino-3-alkyl-3,4,6,7-tetra-hydro-2H-pyrimido(6,1-a)isoquinolin -4-ones, and their use as medicaments | Human Necessities | 0 | Expired |
| US5093331A | Labdane derivatives, a process for their preparation, and their use as medicaments | Chemistry; Metallurgy | 0 | Expired |
| US4479948A | Triazino(2,1-a)isoquinoline derivatives, compositions and their use as medicaments | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.